Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | The Lancet Regional Health. Western Pacific |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606523002456 |